Gemina Laboratories Company Top Insiders
| GLABF Stock | USD 0.05 0.00 0.00% |
Gemina Laboratories employs about 5 people. The company is managed by 4 executives with a total tenure of roughly 12 years, averaging almost 3.0 years of service per executive, having 1.25 employees per reported executive. Management-performance analysis for Gemina Laboratories gives investors another way to evaluate how leadership is influencing execution, capital allocation, and operating discipline. That matters because management quality often influences how well a company responds when business conditions become less favorable.
| David Browning Insider Head Limited |
| Brian Firth Insider Chief Officer |
Gemina |
Management Team Effectiveness
The company has return on total asset (ROA) of -147.65 % indicating that for every $100 in assets, the business produced a $147.65 loss. This is deeply below the industry norm. Similarly, it shows a return on equity (ROE) of -346.71 %, suggesting that retained earnings are insufficient to offset equity losses.Gemina Laboratories holds a significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Of Gemina Laboratories' outstanding shares, about 0% are institutional, 56% insider-held, and 44% in the public float.
Holders Distribution
For Gemina Laboratories, institutional participation can be supportive or destabilizing depending on whether large holders are building conviction or reducing exposure. Used correctly, the ownership map shows where professional sponsorship may be strong and where exit risk could still be significant.
Workforce Comparison
Gemina Laboratories is rated below average in number of employees across its competitive set. The total workforce of Biotechnology industry is currently estimated at about 73.0. Gemina Laboratories holds roughly 5.0 in number of employees claiming about 7% of market share in Biotechnology space.
Benchmark Summation
Operator |
This analysis covers sixty-one data points across the selected time horizon. Gemina Laboratories Price Series Summation is a cross summation of Gemina Laboratories price series and its benchmark/peer.
Notable Stakeholders
Stakeholders matter for Gemina Laboratories because not every influential participant is a shareholder acting with the same objective or time horizon. Gemina Laboratories' stakeholders can support or challenge the entity's direction, which is why tracking them can add context around price-sensitive developments.
| David Browning | Head Limited | Profile | |
| Brian Firth | Chief Officer | Profile | |
| Robert Greene | Chief Director | Profile | |
| Bsc BSc | Chief Sec | Profile |
Management Information & Data Sources
Gemina Laboratories is a micro-cap company. Executive review focuses on insiders, senior management, and employee signals. Executive turnover can affect operating consistency and long-range planning. Gemina Laboratories employs 5 people.
Data shown for Gemina Laboratories is aggregated from periodic company reporting and market reference feeds and normalized across reporting formats. Source publication cadence can introduce delays. Insider and management fields are mapped from published filings and company disclosures.
This content is curated and reviewed by:
Vlad Skutelnik - Macroaxis ContributorWorkforce Efficiency and Productivity
Investors reviewing Gemina Laboratories can use workforce efficiency as another lens on execution, especially when comparing similar businesses in the same industry. Used correctly, manpower metrics can highlight whether growth is being supported by better productivity or by heavier staffing costs.
Gemina Laboratories Manpower Efficiency
Return on Gemina Laboratories Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 947K | |
| Net Loss Per Executive | 1.2M |
Popular Tools for Gemina Pink Sheet analysis
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |